FirstLook uses a unique, advanced technology that analyzes DNA fragment patterns to help screen for lung cancer.2,5
FirstLook makes lung cancer screening accessible to all eligible adults by keeping the process simple.
The FirstLook blood test can be incorporated into routine appointments, making it easier for more adults to get screened for lung cancer.
Whether it’s due to inaccessible screening methods or lack of awareness, the vast majority of eligible adults aren’t getting the nationally recommended low-dose CT screening.4
The FirstLook blood test offers a convenient and accessible way to enhance lung cancer screening.
*The negative predictive value represents the percentage of individuals with a Not Elevated result who do not have low-dose CT detectable lung cancer. The clinical validity of FirstLook Lung was established by a prospective, case-controlled study in a population of screen-eligible patients.2
1. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 365(5), 395-409. 2. Mazzone PJ, et al. Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection. Cancer Discov. 2024 Jun 3. doi: 10.1158/2159-8290.CD-24-0519. Epub ahead of print. PMID: 38829053. 3. Meza, R., Jeon, J., Toumazis, I., Ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., Plevritis, S. K., de Koning, H. J., & Kong, C. Y. (2021). Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. JAMA, 325(10), 988–997. 4. Wang GX, Baggett TP, Pandharipande PV, Park ER, Percac-Lima S, Shepard JO, Fintelmann FJ, Flores EJ. Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective. (2019). Radiology, 290(2), 278-287. 5. Unpublished data on file.